| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/12/2003 | EP1283203A1 Crystalline form of 4-(5-methyl-3-phenylisoxazol-4-yl) benzene-sulfonamide |
| 02/12/2003 | EP1283057A1 Cell proliferation inhibitors |
| 02/12/2003 | EP1283045A1 Drug and food containing glucomannan for inhibiting IgE antibody |
| 02/12/2003 | EP1283042A1 Aqueous liquid preparation |
| 02/12/2003 | EP1282705A2 Endothelial differentiation gene 6-like g protein coupled receptor |
| 02/12/2003 | EP1282643A2 Anti-inflammatory compounds and uses thereof |
| 02/12/2003 | EP1282624A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282622A1 Crf receptor antagonists and methods relating thereto |
| 02/12/2003 | EP1282621A1 Novel vitronectin receptor antagonists |
| 02/12/2003 | EP1282614A1 Hydroxamic acid derivatives |
| 02/12/2003 | EP1282610A1 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments |
| 02/12/2003 | EP1282600A1 Inhibitors of dipeptidyl peptidase iv |
| 02/12/2003 | EP1282592A2 Use of amines |
| 02/12/2003 | EP1282445A2 N-substituted dithiocarbamates for the treatment of biological disorders |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282425A1 Crystal structures of p-selectin, p- and e-selectin complexes, and uses thereof |
| 02/12/2003 | EP1282421A2 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain |
| 02/12/2003 | EP1282420A2 Halogenated 2-amino-3, 4 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1282416A2 Dehydroascorbic acid formulations and uses thereof |
| 02/12/2003 | EP1282413A1 Halogenated 2-amino-5,6 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/12/2003 | EP1140984B1 Selective inhibitors of mmp-12 |
| 02/12/2003 | EP1109534B1 Quick release pharmaceutical compositions of drug substances |
| 02/12/2003 | EP1094833B1 Oxidized thymosin beta 4 |
| 02/12/2003 | EP1049703B1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme |
| 02/12/2003 | EP0988292B1 Piperazine derivatives and their use as anti-inflammatory agents |
| 02/12/2003 | EP0980374B1 Phosphodiesterase 4-inhibiting diazepinoindolones |
| 02/12/2003 | EP0944601B1 Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 02/12/2003 | EP0871623B1 3-azetidinylalkylpiperidines or -pyrrolidines as tachykinin antagonists |
| 02/12/2003 | EP0828488B1 Isothiazolones |
| 02/12/2003 | EP0770079B1 Heterobicyclic derivatives |
| 02/12/2003 | EP0614463B1 Angiostatic steroids |
| 02/12/2003 | CN1396926A Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium 2.5 hydrate or monohydrate |
| 02/12/2003 | CN1396923A 4-Pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 02/12/2003 | CN1396922A Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl acetic acid |
| 02/12/2003 | CN1396918A Formulation for protection against oxidative stress containging benzofuranone derivatives |
| 02/12/2003 | CN1396909A Inhibitors of ICE/ced-3 family of cysteine protease |
| 02/12/2003 | CN1396823A Electrospun pharmaceutical compositions |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395961A Fatty emulsion of goldenrod for injection and its preparing process |
| 02/12/2003 | CN1395957A Plaster for setting up bone, dispersing stasis and analgesia and its preparing process |
| 02/12/2003 | CN1395954A Chinese-medicinal plaster for treating inflammation and pain and its preparing process |
| 02/12/2003 | CN1395937A Application of chrysopdyose in preparing medicine to treat inflammatory enteropathy and its preparing process |
| 02/12/2003 | CN1395922A Theopolyphenol composition for injection and its preparing process |
| 02/12/2003 | CN1101386C Trisubsted phenyl derivitives |
| 02/12/2003 | CN1101228C Treatment of conditions and disease |
| 02/12/2003 | CN1101214C Extenal use disinfectant anagesic and production method thereof |
| 02/12/2003 | CN1101203C Pain-relieving arthralgia dredging Chinese medicine preparation |
| 02/12/2003 | CN1101201C Chinese medicine for making lumber stronger and consolidating vital energy of kidney |
| 02/12/2003 | CN1101197C Medicated wine capable of treating several disease |
| 02/11/2003 | US6518316 Cytokine production and tyrosine kinase inhibitors |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518306 PDE4 inhibitors particularly in regards to treating allergic and inflammatory diseases |
| 02/11/2003 | US6518303 Selectively inhibit COX-2 in preference to COX-1 and are useful in the treatment of COX-2 mediated diseases, such as inflammation, pain, fever and asthma with fewer side effects |
| 02/11/2003 | US6518291 Inosine-5'-monophosphate dehydrogenase inhibitors |
| 02/11/2003 | US6518290 Substituted oxazoles and thiazoles derivatives as HPPAr alpha activators |
| 02/11/2003 | US6518289 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| 02/11/2003 | US6518287 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 02/11/2003 | US6518286 Compounds |
| 02/11/2003 | US6518283 Squaric acid derivatives |
| 02/11/2003 | US6518277 Disrupting leukocyte function |
| 02/11/2003 | US6518267 Protease inhibitors |
| 02/11/2003 | US6518239 Dry powder compositions having improved dispersivity |
| 02/11/2003 | US6518046 DNA (RNA) encoding such chemolcine polypeptides. Moreover, a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such Ck beta -9 polypeptides for the treatment of |
| 02/11/2003 | US6517889 Eliminating or minimizing coating material located within openings; contacting with coating solution then running and rotating a thread through the lumen |
| 02/11/2003 | US6517847 Topical gel delivery system |
| 02/11/2003 | CA2174529C Dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) and uses thereof |
| 02/11/2003 | CA2041818C Separation of enantiomers of cimaterol, (-)-cimaterol and the use thereof as pharmaceutical compositions or as performance enhancers |
| 02/11/2003 | CA2005704C Pneumolysin mutants and pneumococcal vaccines made therefrom |
| 02/10/2003 | WO2002014320A2 Novel substituted diaryl azepine derivatives as integrin ligands |
| 02/10/2003 | CA2419078A1 Substituted diaryl azepine derivatives as integrin ligands |
| 02/06/2003 | WO2003010315A1 Abca7 splicing variant |
| 02/06/2003 | WO2003010299A1 Probiotic lactobacillus casei strains |
| 02/06/2003 | WO2003010298A1 'probiotic lactobacillus salivarius strains |
| 02/06/2003 | WO2003010297A1 Probiotic bifidobacterium strains |
| 02/06/2003 | WO2003010286A2 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 02/06/2003 | WO2003010281A2 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics |
| 02/06/2003 | WO2003010202A1 Concatameric immunoadhesion |
| 02/06/2003 | WO2003010164A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors |
| 02/06/2003 | WO2003010159A1 Piperidine derivatives as nmda receptor antagonists |
| 02/06/2003 | WO2003010158A1 Novel compounds |
| 02/06/2003 | WO2003010135A1 Novel phenylpropionic acid derivatives |
| 02/06/2003 | WO2003010132A1 N-[(1-dimethylaminocycloalkyl)methyl]benzamide derivatives |
| 02/06/2003 | WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases |
| 02/06/2003 | WO2003009866A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent |
| 02/06/2003 | WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor |
| 02/06/2003 | WO2003009843A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 02/06/2003 | WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 02/06/2003 | WO2003009833A1 Sustained release delivery system |
| 02/06/2003 | WO2003009808A2 Methods, compositions and kits relating to chitinases and chitinase-like molecules and inflammatory disease |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2003009805A2 Analgesic methods using endothelin receptor ligands |
| 02/06/2003 | WO2003009803A2 Method of improving cognitive function |
| 02/06/2003 | WO2003009802A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 02/06/2003 | WO2003009800A1 Sustained-release therapeutic bioadhesive systems |
| 02/06/2003 | WO2003009779A2 Delivery of therapeutic capable agents |
| 02/06/2003 | WO2003009778A2 Methods and devices for delivery of therapeutic capable agents with variable release profile |
| 02/06/2003 | WO2003009777A2 Delivery of therapeutic capable agents |
| 02/06/2003 | WO2003009741A2 Methods for treating joint inflammation, pain, and loss of mobility |
| 02/06/2003 | WO2002096423A3 Combination of a pde4 inhibitor and tiotropium or derivate thereof for treating obstructive airways |
| 02/06/2003 | WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |